AI Biomed Predictions
A large corpus of highly relevant, company-specific data powers each prediction, enabling AI to estimate the timing and likelihood of a breakout, key catalysts, target price, squeeze potential, and an ethics grade. Over 700 biopharma companies form the universe of the Biomed Prediction Engine (BPE), each thoroughly analyzed to expose their breakout potential—exclusively on ScanScor.com.